Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? (Q33442816)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

circulatory system

1 reference

based on heuristic

inferred from title

Kentaro Hayashida

object named as

Kentaro Hayashida

3

0 references

author name string

Yoshihiko Suzuki

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Motoaki Sano

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ikuroh Ohsawa

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shigeo Ohta

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Keiichi Fukuda

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

6 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

583

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2157-2159

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Redox regulation of the afferent arteriole and tubuloglomerular feedback

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Why have antioxidants failed in clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

A role for oxidized phospholipids in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Production and excretion of hydrogen gas in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2009.05.052

21 January 2018

Identifiers

10.1016/J.FEBSLET.2009.05.052

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33442816&oldid=1536136735"